Javascript must be enabled to continue!
Associations of metal exposure with hyperuricemia and gout in general adults
View through CrossRef
BackgroundEpidemiological evidence of the associations between metal exposure and gout-related outcomes (including serum uric acid [SUA], hyperuricemia and gout) is scarce. The aim of the study is to investigate the associations of metal exposure with SUA, hyperuricemia and gout in general adults.MethodsIn this study, the exposure to five blood metals (mercury, manganese, lead, cadmium and selenium) of general adults was analyzed based on the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2018 (n = 14,871). Linear, logistic and weighted quantile sum (WQS) regression models were applied to examine the associations of blood metals with gout-related outcomes. Possible dose-response relationships were analyzed through restricted cubic spline regression.ResultsCompared with the lowest quartile of blood metals, mercury (quartile 2 and 4), lead (quartile 2, 3, and 4) and selenium (quartile 2 and 4) were found to be positively correlated with SUA and hyperuricemia. Higher levels of mercury and lead were associated with gout, but only those in the fourth quartile had statistical significance (OR [95%CI]: 1.39 [1.10-1.75] and 1.905 [1.41-2.57]) respectively). The WQS index of the blood metals was independently correlated with SUA (β [95%CI]: 0.17 [0.13-0.20]), hyperuricemia (OR [95%CI]: 1.29 [1.16-1.42]) and gout (OR [95%CI]: 1.35 [1.15-1.58]). Among them, lead was the most heavily weighted component (weight = 0.589 for SUA, 0.482 for hyperuricemia, and 0.527 for gout). In addition, restricted cubic spline regression models showed a linear association of lead with the prevalence of hyperuricemia and gout.ConclusionOur results suggested that blood metal mixtures were positively associated with gout-related outcomes, with the greatest effect coming from lead.
Frontiers Media SA
Title: Associations of metal exposure with hyperuricemia and gout in general adults
Description:
BackgroundEpidemiological evidence of the associations between metal exposure and gout-related outcomes (including serum uric acid [SUA], hyperuricemia and gout) is scarce.
The aim of the study is to investigate the associations of metal exposure with SUA, hyperuricemia and gout in general adults.
MethodsIn this study, the exposure to five blood metals (mercury, manganese, lead, cadmium and selenium) of general adults was analyzed based on the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2018 (n = 14,871).
Linear, logistic and weighted quantile sum (WQS) regression models were applied to examine the associations of blood metals with gout-related outcomes.
Possible dose-response relationships were analyzed through restricted cubic spline regression.
ResultsCompared with the lowest quartile of blood metals, mercury (quartile 2 and 4), lead (quartile 2, 3, and 4) and selenium (quartile 2 and 4) were found to be positively correlated with SUA and hyperuricemia.
Higher levels of mercury and lead were associated with gout, but only those in the fourth quartile had statistical significance (OR [95%CI]: 1.
39 [1.
10-1.
75] and 1.
905 [1.
41-2.
57]) respectively).
The WQS index of the blood metals was independently correlated with SUA (β [95%CI]: 0.
17 [0.
13-0.
20]), hyperuricemia (OR [95%CI]: 1.
29 [1.
16-1.
42]) and gout (OR [95%CI]: 1.
35 [1.
15-1.
58]).
Among them, lead was the most heavily weighted component (weight = 0.
589 for SUA, 0.
482 for hyperuricemia, and 0.
527 for gout).
In addition, restricted cubic spline regression models showed a linear association of lead with the prevalence of hyperuricemia and gout.
ConclusionOur results suggested that blood metal mixtures were positively associated with gout-related outcomes, with the greatest effect coming from lead.
Related Results
HYPERURICEMIA AND ITS ASSOCIATION WITH HYPERTENSION: RISK FACTORS AND MANAGEMENT
HYPERURICEMIA AND ITS ASSOCIATION WITH HYPERTENSION: RISK FACTORS AND MANAGEMENT
Hyperuricemia is a medical condition that arises due to the increased concentration of uric acid in the body. Worldwide, a surge in the number of hyperuricemia cases has been seen ...
Physical Function, Hyperuricemia, and Gout in Older Adults
Physical Function, Hyperuricemia, and Gout in Older Adults
ObjectiveGout prevalence is high in older adults and those affected are at risk of physical disability, yet it is unclear whether they have worse physical function.MethodsWe studie...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Hypertension and gout: A Mendelian randomization study
Hypertension and gout: A Mendelian randomization study
Abstract
Background: Although there is solid epidemiological evidence supporting the connection between hypertension and gout, the causal relationship and direction associa...
A u-shape association of serum uric acid with gout in US adults
A u-shape association of serum uric acid with gout in US adults
AbstractBackgroundSerum uric acid (SUA) level is the strongest determinant of gout, and the relationship between hyperuricemia and gout has been found. However, the association bet...
Association between the aggregate index of systemic inflammation and hyperuricemia: evidence from NHANES 2011–2018
Association between the aggregate index of systemic inflammation and hyperuricemia: evidence from NHANES 2011–2018
Abstract
Objective
The aim of this study was to explore the association between the Aggregate Index of Systemic Inflammation (AISI) and hyperuricemia, using data from the ...
Study on the diagnosis of gout with xanthine and hypoxanthine
Study on the diagnosis of gout with xanthine and hypoxanthine
BackgroundHyperuricemia is the only biochemical index in the classification of acute gouty arthritis in American Rheumatism Association 1977 and the main basis of clinical diagnosi...
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are the fastest-growing cause of death around the world, and atherosclerosis plays a major role in the etiology of CVDs. The most recent figures show...

